Alessia Liccardi

879 citations
21 papers · 389 indexed · h-index 10
Topics
Neuroendocrine Tumor Research Advances (12 papers)Lung Cancer Research Studies (9 papers)Neuroblastoma Research and Treatments (6 papers)
Partner nations
ItalyGermany

In The Last Decade

Alessia Liccardi

18 papers receiving 380 citations

Peers

Alessia Liccardi
Comparison fields: 5 of 79
  • Epidemiology 166
  • Oncology 95
  • Molecular Biology 57
  • Endocrinology, Diabetes and Metabolism 56
  • Surgery 49
Replace Min Min with:
Min Min China
Elita Stonāne Germany
Yoshihisa Hanayama Japan
Jeffrey T. Kirchner United States
Maryam Afrakhteh Iran
Israel Tamir Israel
Shuji Mitsuhashi United States
Erdem Gönüllü Türkiye
Luca Pierri Italy
Alessia Liccardi relative to Min Min China Min Min's profile →
Citations per field
00.5×4.7×
Min Min · 1×
Citations per year

Countries citing papers authored by Alessia Liccardi

Since Specialization
Citations

This map shows the geographic impact of Alessia Liccardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia Liccardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia Liccardi more than expected).

Fields of papers citing papers by Alessia Liccardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia Liccardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia Liccardi. The network helps show where Alessia Liccardi may publish in the future.

Co-authorship network of co-authors of Alessia Liccardi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessia Liccardi. A scholar is included among the top collaborators of Alessia Liccardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessia Liccardi. Alessia Liccardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 7
5 10
6 0
7 5
8 5
9 9
10 3
11 25
12 9
13 102
14 14
15 23
16 69
17 24
18 34
19 3
20 19

About Alessia Liccardi

Alessia Liccardi is a scholar working on Neurology, Epidemiology and Oncology, having authored 21 papers that have together received 389 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (12 papers), Lung Cancer Research Studies (9 papers) and Neuroblastoma Research and Treatments (6 papers). The work is most often cited by research in Microbiology (45 citations), Epidemiology (166 citations) and Oncology (95 citations). Alessia Liccardi has collaborated with scholars based in Italy and Germany. Frequent co-authors include Annamaria Colao, Annamaria Colao, Giovanna Muscogiuri, Chiara Graziadio, Gabriella Pugliese, Luigi Barrea, Roberta Modica, Rosario Pivonello, Renata S. Auriemma and Rosa Pirchio. Their work appears in journals such as International Journal of Molecular Sciences, International Journal of Obesity and Obesity Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026